Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

Hanny Al-Samkari, MD, Rachael F. Grace, MD, Andreas Glenthoej, MD, Oliver Andres, MD, Wilma Barcellini, Frédéric Galactéros, MDPhD, Kevin H.M. Kuo, MDMSc,FRCPC, D. Mark Layton, MB BS, Marta Morado, PhD, Vip Viprakasit, Yan Dong, PhD, Feng Tai, PhD, Peter Hawkins, PhD, Sarah Gheuens, MD PhD, Chris Bowden, MD, John B. Porter, MA, MD, FRCP, FRCPath, Eduard van Beers, MD PhD

Blood (2020) 136 (Supplement 1): 30–32.

https://doi.org/10.1182/blood-2020-136598

Published: 2020

Journal Articles

Characteristics of Children and Adults Treated with Rituximab for Immune Thrombocytopenia (ITP)

Emily M. Harris, MD, Kirsty Hillier, MD, Hanny Al-Samkari, MD, Peter W. Forbes, BS, Rachael F. Grace, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-138856

Published: 2020

Journal Articles

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Orly Leiva, MD, Olesya Baker, PhD, Andrew M. Brunner, Hanny Al-Samkari, MD, Rebecca Karp Leaf, MD, Rachel P. Rosovsky, MD MPH, Amir T. Fathi, MD, James I Weitzman, MD, Larissa Bornikova, MD, Valentina Nardi, MD, Gabriela S. Hobbs, MD

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-137311

Published: 2020

Journal Articles

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Hanny Al-Samkari, MD, Alexandria Cronin, MLIS, Donald M. Arnold, MD MSc, Francesco Rodeghiero, MD, Rachael F. Grace, MD

Blood (2020) 136 (Supplement 1): 45–46.

https://doi.org/10.1182/blood-2020-138694

Published: 2020

Journal Articles

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19

Hanny Al-Samkari, MD, Fei Song, MD, Elizabeth M. Van Cott, MD, David J. Kuter, MD, Rachel P. Rosovsky, MD MPH

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-134605

Published: 2020

Journal Articles

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

Blood (2019) 134 (Supplement_1): 949.

https://doi.org/10.1182/blood-2019-125352

Published: 2019

Journal Articles

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Hanny Al-Samkari, MD, Raj S. Kasthuri, MD, Hasan A. Albitar, MD, Yahya Almodallal, MBBS, Marcelo M. Serra, MD, Carolina Vazquez, MD, Sophie Dupuis-Girod, MD PhD, Clifford R. Weiss, MD, Muhammad A. Latif, MD, Mary Elizabeth Meek, MD, David J. Kuter, Vivek N. Iyer, MD MPH

Blood (2019) 134 (Supplement_1): 1060.

https://doi.org/10.1182/blood-2019-129418

Published: 2019

Journal Articles

Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency

Blood (2019) 134 (Supplement_1): 2175.

https://doi.org/10.1182/blood-2019-123069

Published: 2019

Journal Articles

Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency

Kathryn Addonizio, BA, Hanny Al-Samkari, MD, Bertil Glader, MD PhD, D Holmes Morton, MD, Satheesh Chonat, MD, Alexis A. Thompson, MD MPH, Kevin H. M. Kuo, MDMSc,FRCPC, Yaddanapudi Ravindranath, MBBS, Heng Wang, MD PhD, Jennifer A. Rothman, MD, Janet L. Kwiatkowski, MD MSCE, Charles Kung, PhD, Penelope A. Kosinski, MS, Hasan Al-Sayegh, MS, Wendy B. London, PhD, Rachael F. Grace, MD

Blood (2019) 134 (Supplement_1): 3515.

https://doi.org/10.1182/blood-2019-125248

Published: 2019

Journal Articles

Long-Term Response Rates in Patients with Chronic Immune Thrombocytopenia Treated with Avatrombopag: Additional Analyses from a Phase 3 Study and Its Extension Phase

Hanny Al-Samkari, MD, Kavita Aggarwal, PharmD, Michael Vredenburg, PhD, Wei Tian, PhD, Lee F. Allen, MD PhD

Blood (2019) 134 (Supplement_1): 2356.

https://doi.org/10.1182/blood-2019-131215

Published: 2019

Journal Articles

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies

Hanny Al-Samkari, MD, Aric D Parnes, MD, Katayoon Goodarzi, MD, James I Weitzman, MD, Jean M. Connors, MD, David J. Kuter

Blood (2019) 134 (Supplement_1): 389.

https://doi.org/10.1182/blood-2019-123864

Published: 2019

Journal Articles

Serum Complement Levels in Immune Thrombocytopenia: Characterization and Relation to Clinical Features

Abraham Z Cheloff, MS, David J. Kuter, Hanny Al-Samkari, MD

Blood (2019) 134 (Supplement_1): 1087.

https://doi.org/10.1182/blood-2019-125341

Published: 2019

Journal Articles

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Hanny Al-Samkari, MD, Stacy E. Croteau

Blood (2019) 134 (Supplement_1): 3395.

https://doi.org/10.1182/blood-2019-125364

Published: 2019

Journal Articles

Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia

Andrew B Song, BA, David J. Kuter, Hanny Al-Samkari, MD

Blood (2019) 134 (Supplement_1): 959.

https://doi.org/10.1182/blood-2019-122359

Published: 2019

Journal Articles

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

Hanny Al-Samkari, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 734.

https://doi.org/10.1182/blood-2018-99-117267

Published: 2018

Journal Articles

Antiplatelet Antibody Testing in Immune Thrombocytopenia and Evans Syndrome: Longitudinal Serologic Evolution and Relation to Clinical Features

Hanny Al-Samkari, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 1137.

https://doi.org/10.1182/blood-2018-99-118403

Published: 2018

Journal Articles

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Hanny Al-Samkari, MD, Athena Kritharis, MD, Josanna Rodriguez-Lopez, MD, David J. Kuter, MD DPhil

Blood (2018) 132 (Supplement 1): 852.

https://doi.org/10.1182/blood-2018-99-117144

Published: 2018

Journal Articles

Romiplostim for the Management of Perioperative Thrombocytopenia

Hanny Al-Samkari, MD, Ariela L. Marshall, MD, Katayoon Goodarzi, MD, David J Kuter, MD DPhil

Blood (2017) 130 (Supplement 1): 1037.

https://doi.org/10.1182/blood.V130.Suppl_1.1037.1037

Published: 2017

Journal Articles

Romiplostim for Treatment and Prevention of Chemotherapy-Associated Thrombocytopenia

Hanny Al-Samkari, MD, David J Kuter, MD DPhil, Katayoon Goodarzi, MD, Ariela L. Marshall, MD

Blood (2016) 128 (22): 3748.

https://doi.org/10.1182/blood.V128.22.3748.3748

Published: 2016

NARROW

Early-Onset Osteopenia and Osteoporosis in Patients with Pyruvate Kinase Deficiency

Characteristics of Children and Adults Treated with Rituximab for Immune Thrombocytopenia (ITP)

Rates of Thrombotic Events in Hypereosinophilic Syndrome and the Effect of Molecular Aberrations in Thrombotic Risk

Extensive Variability in Platelet Count, Bleeding, and Quality of Life Outcome Measures in Adult and Pediatric Immune Thrombocytopenia: An Appraisal from a Critical Review of the Literature

Evaluation of the Prothrombin Fragment 1.2 in Patients with COVID-19

Characterization of the Severe Phenotype of Pyruvate Kinase Deficiency

An International Multicenter Study of Intravenous Bevacizumab for the Treatment of Chronic Bleeding and Anemia in Hereditary Hemorrhagic Telangiectasia: The Inhibit-Bleed Study

Comorbidities and Complications in Adults with Pyruvate Kinase Deficiency

Pyruvate Kinase (PK) Protein and Enzyme Levels in the Diagnosis and Clinical Phenotype of PK Deficiency

Long-Term Response Rates in Patients with Chronic Immune Thrombocytopenia Treated with Avatrombopag: Additional Analyses from a Phase 3 Study and Its Extension Phase

A Multicenter Study of Romiplostim to Treat Chemotherapy-Induced Thrombocytopenia in Solid Tumors and Lymphoid Malignancies

Serum Complement Levels in Immune Thrombocytopenia: Characterization and Relation to Clinical Features

Beliefs, Opinions, and Impact of Emicizumab on Hemophilia Patients: A National U.S. Survey

Characterization of the Rate, Predictors, and Thrombotic Complications of Thrombocytosis in Iron Deficiency Anemia

Thrombopoietin Level Predicts Response to Treatment with Eltrombopag and Romiplostim in Immune Thrombocytopenia

Antiplatelet Antibody Testing in Immune Thrombocytopenia and Evans Syndrome: Longitudinal Serologic Evolution and Relation to Clinical Features

Systemic Bevacizumab for the Treatment of Chronic Bleeding in Hereditary Hemorrhagic Telangiectasia

Romiplostim for the Management of Perioperative Thrombocytopenia

Romiplostim for Treatment and Prevention of Chemotherapy-Associated Thrombocytopenia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only